Dmitrij Hristodorov

Dmitrij Hristodorov is a Principal at Forbion. Prior to this, he was Senior Director of Global Business Development & Licensing at Bayer Pharma, where he was mainly responsible for ophthalmology, cardiology, nephrology, and pulmonology. His spectrum of activities included scouting, evaluation, negotiation, and transaction for in- and out-licensing. Previously, Dmitrij spent two years in R&D as Head of Pharmacology Lab in Ophthalmology. His activities included target discovery and preclinical development. Dmitrij received his PhD in Immunology (summa cum laude) from the University of Aachen/Fraunhofer IME, Germany, in 2013.